SILVERARC CAPITAL MANAGEMENT, LLC

CIK 0001816307 · BOSTON, MA · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

SILVERARC CAPITAL MANAGEMENT, LLC reported 73 positions worth $962.2M as of June 30, 2026 (13F filed August 13, 2026). Largest holding: ASND (5.7%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$962.2M
2026 Q2
Positions
73
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
42.3%
Est. Net Flow (Q)
2026 Q2
10 / 73 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1ASNDASCENDIS PHARMA A/SSH$55.0M5.72%206,234
2CELCCELCUITY INCSH$52.4M5.45%500,996
3COGTCOGENT BIOSCIENCES INCSH$49.6M5.15%1,280,707
4URGNUROGEN PHARMA LTDSH$47.9M4.98%1,301,979
5IMNMIMMUNOME INCSH$42.7M4.44%2,017,009
6DNTHDIANTHUS THERAPEUTICS INCSH$38.0M3.95%390,000
7RYTMRHYTHM PHARMACEUTICALS INCSH$34.6M3.59%311,461
8ORKAORUKA THERAPEUTICS INCSH$33.6M3.49%352,802
9GLUEMONTE ROSA THERAPEUTICS INCSH$26.8M2.79%1,108,295
10SNDXSYNDAX PHARMACEUTICALS INCSH$26.5M2.76%1,214,390

The free plan shows the top 10 positions. The remaining 63 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does SILVERARC CAPITAL MANAGEMENT, LLC hold as of Q2 2026?

SILVERARC CAPITAL MANAGEMENT, LLC reported 73 positions worth $962.2M in its Q2 2026 13F filing. Largest positions: ASND (5.7%), CELC (5.4%), COGT (5.2%), URGN (5.0%) and IMNM (4.4%).

What did SILVERARC CAPITAL MANAGEMENT, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did SILVERARC CAPITAL MANAGEMENT, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.